Drugs and Treatments for Autoimmune Diseases: Global Markets

Drugs and Treatments for Autoimmune Diseases: Global Markets

Report Code: HLC091A

Publish Date: Oct 2011

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for autoimmune treatments reached at $34 billion in 2010, it is expected to reach at $38.9 billion by 2011 and it will further grow to $55 billion by 2016 at a compounded annual growth rate (CAGR) of 7.2%.

SCOPE OF REPORT

This report offers forecasts by product segment, disease, and geographical region from 2011 through 2016, including supporting analyses for projections.

This report is a valuable tool for anyone assessing the autoimmune market and attempting to devise a strategy for successful competition within it.  It provides a thorough background on the structure of the autoimmune market and the chief challenges and opportunities it faces.  It offers the information necessary for understanding the current market and for addressing the emerging one. 

ANALYST CREDENTIALS

Peggy S. Lehr is the BCC Research Analyst of this report.  Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder and an MS in Communication from the University of Denver.  Ms. Lehr has completed more than 13 reports for BCC, primarily on the medical and pharmaceutical industries.  She has worked within the publishing industry for both for-profit and not-for-profit organizations. 

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? Explore Offers
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Drugs and Treatments for Autoimmune Diseases: Global Markets154Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW OF AUTOIMMUNE DISEASE10Free
Chapter- 4: MARKET FOR AUTOIMMUNE PHARMACEUTICALS33Free
Chapter- 5: GLOBAL AUTOIMMUNE PHARMACEUTICAL THERAPIES MARKET13Free
Chapter- 6: AUTOIMMUNE DISEASE PHARMACEUTICAL MARKET BY PHARMACEUTICAL TYPE21Free
Chapter- 7: AUTOIMMUNE DIAGNOSTIC TESTING MARKET9Free
Chapter- 8: AUTOIMMUNE TREATMENT ASSISTIVE TECHNOLOGIES5Free
Chapter- 9: CURRENT RESEARCH AND EMERGING PHARMACEUTICALS10Free
Chapter- 10: REGULATIONS AND PATENTS9Free
Chapter- 11: COMPANY DIRECTORY38Free

Related Reports

Medical Enzymes: Technologies and Global Markets

Published - Mar 2011 | Publisher - Shalini Shahani Dewan | Code - BIO082A

The market for enzymes in medicine is growing. The global market for medical enzymes is estimated at $6 billion in 2010. The market is growing at a compound annual growth rate (CAGR) of 3.9%, to reach $7.2 billion in 2015.

Therapeutics for Immune System Disorders

Published - Jan 2011 | Publisher - Syamala Ariyanchira | Code - BIO025D

In 2010, the global market for drugs for the treatment of immune disease was estimated to be approximately $72.2 billion.  The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 59

  • Summary Table: GLOBAL MARKET FOR AUTOIMMUNE TREATMENTS, THROUGH 2016
  • Table 1: INFECTIONS IN HUMANS ASSOCIATED WITH SELECTED AUTOIMMUNE DISEASES
  • Table 2: RECOGNIZED AND POTENTIAL AUTOIMMUNE DISEASES AND THE SYSTEMS THEY EFFECT, 2011
  • Table 3: GLOBAL MARKET FOR PHARMACEUTICAL THERAPIES FOR LEADING AUTOIMMUNE DISEASES, THROUGH 2016
  • Table 4: AMERICAN COLLEGE OF RHEUMATOLOGY RECOMMENDATIONS FOR RA TREATMENTS, 2008
  • Table 5: GLOBAL MARKET FOR RHEUMATOID ARTHRITIS MEDICATIONS, THROUGH 2016
  • Table 6: GLOBAL MARKET FOR TYPE 1 DIABETES PHARMACEUTICAL PRODUCTS, THROUGH 2016
  • Table 7: MAJOR MANUFACTURERS OF DIABETES PRODUCTS, 2011
  • Table 8: PHARMACEUTICAL TREATMENTS FOR SYSTEMIC LUPUS ERYTHEMATOSUS BY CONDITION TYPE, 2011
  • Table 9: INVESTIGATIONAL TREATMENTS FOR SYSTEMIC LUPUS ERYTHEMATOSUS, 2011
  • Table 10: GLOBAL MARKET FOR PHARMACEUTICALS TO TREAT LUPUS, THROUGH 2016
Sample Report

Recent Reports

Anesthesia and Respiratory Devices: Global Markets

Published - Aug 2025 | Publisher - BCC Publishing | Code - HLC167E

The global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2025 to 2030.

Tissue Engineering and Regeneration: Technologies and Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC101E

The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.

6G in Healthcare: Global Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC306A

This report provides an analysis of the global market trends for 6G in healthcare. It focuses on the significant driving trends and challenges that affect the global market. The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for 6G in healthcare.

Healthcare Innovation in the GCC

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC307A

The report provides an analysis of the healthcare landscape in the Gulf Cooperation Council (GCC) countries. The report estimates the Total Addressable Market (TAM) for the GCC healthcare sector from 2024 to 2030, offering country-specific projections. This analysis provides critical insights into the commercial potential and investment opportunities in the region’s rapidly evolving healthcare ecosystem. The countries included in the analysis are Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Oman, and Bahrain.

Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa

Published - Jun 2025 | Publisher - BCC Publishing | Code - HLC305A

This report presents an in-depth analysis of the MENA beauty and personal care market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, opportunities, and market projections for 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Drugs and Treatments for Autoimmune Diseases: Global Markets
Customize Report